Clinical trial
CONVINCE - (COlchicine for preventioN of Vascular Inflammation in Non- CardioEmbolic Stroke) - a Randomised Clinical Trial of Low-dose Colchicine for Secondary Prevention After Stroke
NCT02898610 is registered in ClinicalTrials.gov with University College Dublin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CONVINCE - (COlchicine for preventioN of Vascular Inflammation in Non- CardioEmbolic Stroke) - a Randomised Clinical Trial of Low-dose Colchicine for Secondary Prevention After Stroke
- Lead sponsor
- University College Dublin
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 12, 2016
- Completion date
- January 31, 2024
- Enrollment
- 3,154 (actual)
- Sites
- 145
Conditions
As the registry lists them; a condition with its own page is linked.